URINARY GM2 ACTIVATOR PROTEIN AS A MARKER OF ACUTE RENAL FAILURE OR THE RISK OF DEVELOPING ACUTE RENAL FAILURE

The invention relates to a method of determining the risk of developing acute renal failure (ARF) in an individual, or of determining an ARF, and a method of predicting the progression of an ARF, by detecting and/or quantifying the protein Ganglioside GM2 Activator Protein (GM2AP). The failure can b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	QUIROS LUIS, YAREMI, SANCHO MARTINEZ, SANDRA MARIA, GONZALEZ DE BUITRAGO ARRIERO, JOSE MANUEL, LOPEZ HERNANDEZ, FRANCISCO JOSE, FERREIRA REDONDO, LAURA, LOPEZ NOVOA, JOSE MIGUEL
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!